What is the appropriate medical management for a patient with low serum iron (18 µg/dL) and low transferrin saturation (5 %)?

Medical Management for Severe Iron Deficiency

Start oral ferrous sulfate 200 mg once daily immediately with vitamin C 500 mg, and arrange urgent bidirectional endoscopy to exclude gastrointestinal malignancy. 1

Diagnostic Confirmation

Your laboratory values confirm absolute iron deficiency:

• Iron saturation 5% is profoundly low (normal >20%), indicating severe iron depletion that warrants immediate treatment 2
• Serum iron 18 µg/dL is critically low and independently predicts anemia risk even when transferrin saturation appears borderline 3
• These values together define absolute iron deficiency requiring supplementation without delay 1, 2

Immediate Oral Iron Therapy

First-line regimen:

• Ferrous sulfate 200 mg (containing ~65 mg elemental iron) once daily on an empty stomach 1, 2
• Add vitamin C 500 mg with each iron dose—this is critical when transferrin saturation is severely low like yours, as it markedly enhances absorption 1, 2, 4
• Once-daily dosing is superior to multiple daily doses because hepcidin remains elevated for ~48 hours after iron intake, blocking further absorption and increasing side effects without improving efficacy 1
• If ferrous sulfate causes intolerable gastrointestinal side effects, switch to ferrous fumarate (106 mg elemental iron) or ferrous gluconate (38 mg elemental iron)—these are equally effective 1

Timing considerations:

• Take on an empty stomach for maximal absorption; if gastrointestinal irritation occurs, taking with food is acceptable 1
• Avoid tea and coffee within 1 hour of the iron dose, as these strongly inhibit absorption 1

Expected Response and Monitoring

• Check hemoglobin at 4 weeks—expect a rise of approximately 2 g/dL 1, 2, 4
• Failure to achieve at least a 1 g/dL rise by 4 weeks indicates poor compliance, continued blood loss, malabsorption, or need for IV iron 1, 5
• Continue oral iron for 3 months after hemoglobin normalizes to fully replenish iron stores—total treatment duration is typically 6–7 months 1, 2, 4
• Monitor hemoglobin and red-cell indices every 3 months during the first year, then annually 1

Mandatory Investigation of Underlying Cause

Do not delay iron therapy while awaiting diagnostic work-up, unless colonoscopy is scheduled within the next few days (iron can impair endoscopic visualization). 1, 2

All patients require investigation:

• Men and postmenopausal women: Bidirectional endoscopy (upper endoscopy + colonoscopy) is mandatory to exclude gastrointestinal malignancy, as iron deficiency may be the sole presenting sign 1, 2
• Premenopausal women: First assess menstrual blood loss (menorrhagia accounts for 5–10% of iron deficiency in menstruating women); reserve endoscopy for those ≥45 years, with upper GI symptoms, alarm features, or family history of colorectal cancer 1, 2
• Screen for celiac disease with tissue transglutaminase IgA antibodies and total IgA measurement—celiac disease is present in 3–5% of iron-deficiency cases and causes treatment failure if missed 1, 2
• Test for Helicobacter pylori using stool antigen or urea-breath test and eradicate if positive 1

When to Switch to Intravenous Iron

Switch to IV iron if any of the following occur:

• Intolerance to at least two different oral iron preparations (e.g., ferrous sulfate and ferrous fumarate) 1, 2
• Ferritin does not improve after 4 weeks of compliant oral therapy 1, 2
• Hemoglobin fails to rise by ≥1 g/dL after 4 weeks 1
• Active inflammatory bowel disease with hemoglobin <10 g/dL (inflammation-driven hepcidin blocks oral absorption) 1, 2
• Post-bariatric surgery patients (disrupted duodenal absorption) 1
• Celiac disease with inadequate response despite strict gluten-free diet 1
• Ongoing gastrointestinal blood loss exceeding oral replacement capacity 1

Preferred IV iron formulations:

• Ferric carboxymaltose: 750–1000 mg per 15-minute infusion; two doses ≥7 days apart provide 1500 mg total 1, 2
• Ferric derisomaltose: 1000 mg as a single infusion 1
• Avoid iron dextran as first-line due to higher anaphylaxis risk (~0.6–0.7%) 1
• All IV iron must be administered in a setting equipped with resuscitation facilities 1

Critical Pitfalls to Avoid

• Do not prescribe multiple daily doses of oral iron—this increases side effects without improving efficacy due to hepcidin-mediated absorption blockade 1
• Do not stop iron therapy when hemoglobin normalizes—continue for an additional 3 months to restore stores 1, 2
• Do not persist with oral iron beyond 4 weeks without a hemoglobin rise—reassess for malabsorption, ongoing loss, or need for IV iron 1
• Do not overlook vitamin C supplementation when oral iron response is suboptimal 1, 2
• Do not delay endoscopic evaluation in high-risk patients (age ≥50, alarm symptoms, or treatment failure), as gastrointestinal malignancy may present solely with iron deficiency 1, 2

Special Considerations

If you have chronic kidney disease (CKD):

• In CKD stages 3–5 not on dialysis, absolute iron deficiency is defined as transferrin saturation ≤20% and ferritin ≤100 ng/mL (higher threshold than general population due to inflammation) 6, 7
• If hemoglobin <11 g/dL with these iron parameters, start iron supplementation (oral or IV) 6
• Hemodialysis patients require IV iron as the preferred route 6

If you have chronic heart failure:

• IV iron improves symptoms and quality of life even with functional iron deficiency (ferritin <100 ng/mL or transferrin saturation <20%) 1, 8
• Low transferrin saturation is more strongly associated with adverse outcomes than ferritin in heart failure 8